Cargando…
One-year performance of posterior narrow diameter implants in hyperglycemic and normo-glycemic patients—a pilot study
OBJECTIVES: The aim of the study was to compare the performance of narrow diameter implants in patients with uncontrolled diabetes mellitus type 2 (T2DM) and normo-glycemic individuals during the first 12 months after implant loading. MATERIAL AND METHODS: In 16 T2DM patients with HbA1C > 6.5% (t...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602141/ https://www.ncbi.nlm.nih.gov/pubmed/33939006 http://dx.doi.org/10.1007/s00784-021-03957-x |
_version_ | 1784601515625807872 |
---|---|
author | Friedmann, Anton Winkler, Marianna Diehl, Daniel Yildiz, Mehmet Selim Bilhan, Hakan |
author_facet | Friedmann, Anton Winkler, Marianna Diehl, Daniel Yildiz, Mehmet Selim Bilhan, Hakan |
author_sort | Friedmann, Anton |
collection | PubMed |
description | OBJECTIVES: The aim of the study was to compare the performance of narrow diameter implants in patients with uncontrolled diabetes mellitus type 2 (T2DM) and normo-glycemic individuals during the first 12 months after implant loading. MATERIAL AND METHODS: In 16 T2DM patients with HbA1C > 6.5% (test group) and 16 normo-glycemic patients (HbA1C < 6.0%; control group), one to two narrow diameter tissue level implants were placed in the posterior maxilla or mandible. After 3-month lasting integration period, implants were loaded by fixed dentures. The clinical parameters probing depth (PD), bleeding on probing (BOP), attachment loss (CAL), recession and papilla bleeding index (PBI) were assessed manually at loading and after 12 months of function. The paired digital periapical radiographs were analyzed with regard to the change in marginal bone level (MBL) from baseline to 12 months’ control. The mean values calculated for both patient groups were statistically analyzed. The technical complications were recorded. RESULTS: The T2DM group accounted 13 patients due to 3 dropouts. The overall implant survival rate after 12 months was 100%. The differences in means for the clinical parameters and the MBL were statistically non-significant between the T2DM and normo-glycemic patients for the short period of loaded function reported here. No technical complications were recorded. CONCLUSIONS: The study demonstrated an encouraging clinical outcome with narrow diameter implants in patients with uncontrolled T2DM compared to non-diabetics after 12 months post loading. For the short observation period, no biological and technical complications were reported regardless the glycemic status. CLINICAL RELEVANCE: Patients with HbA1C > 6.5% may benefit from the treatment with narrow diameter implants by avoiding complex surgical interventions with augmentation procedures. TRIAL REGISTRATION: Clinicaltrials.gov: NCT04630691 SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00784-021-03957-x. |
format | Online Article Text |
id | pubmed-8602141 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-86021412021-12-03 One-year performance of posterior narrow diameter implants in hyperglycemic and normo-glycemic patients—a pilot study Friedmann, Anton Winkler, Marianna Diehl, Daniel Yildiz, Mehmet Selim Bilhan, Hakan Clin Oral Investig Original Article OBJECTIVES: The aim of the study was to compare the performance of narrow diameter implants in patients with uncontrolled diabetes mellitus type 2 (T2DM) and normo-glycemic individuals during the first 12 months after implant loading. MATERIAL AND METHODS: In 16 T2DM patients with HbA1C > 6.5% (test group) and 16 normo-glycemic patients (HbA1C < 6.0%; control group), one to two narrow diameter tissue level implants were placed in the posterior maxilla or mandible. After 3-month lasting integration period, implants were loaded by fixed dentures. The clinical parameters probing depth (PD), bleeding on probing (BOP), attachment loss (CAL), recession and papilla bleeding index (PBI) were assessed manually at loading and after 12 months of function. The paired digital periapical radiographs were analyzed with regard to the change in marginal bone level (MBL) from baseline to 12 months’ control. The mean values calculated for both patient groups were statistically analyzed. The technical complications were recorded. RESULTS: The T2DM group accounted 13 patients due to 3 dropouts. The overall implant survival rate after 12 months was 100%. The differences in means for the clinical parameters and the MBL were statistically non-significant between the T2DM and normo-glycemic patients for the short period of loaded function reported here. No technical complications were recorded. CONCLUSIONS: The study demonstrated an encouraging clinical outcome with narrow diameter implants in patients with uncontrolled T2DM compared to non-diabetics after 12 months post loading. For the short observation period, no biological and technical complications were reported regardless the glycemic status. CLINICAL RELEVANCE: Patients with HbA1C > 6.5% may benefit from the treatment with narrow diameter implants by avoiding complex surgical interventions with augmentation procedures. TRIAL REGISTRATION: Clinicaltrials.gov: NCT04630691 SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00784-021-03957-x. Springer Berlin Heidelberg 2021-05-03 2021 /pmc/articles/PMC8602141/ /pubmed/33939006 http://dx.doi.org/10.1007/s00784-021-03957-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Friedmann, Anton Winkler, Marianna Diehl, Daniel Yildiz, Mehmet Selim Bilhan, Hakan One-year performance of posterior narrow diameter implants in hyperglycemic and normo-glycemic patients—a pilot study |
title | One-year performance of posterior narrow diameter implants in hyperglycemic and normo-glycemic patients—a pilot study |
title_full | One-year performance of posterior narrow diameter implants in hyperglycemic and normo-glycemic patients—a pilot study |
title_fullStr | One-year performance of posterior narrow diameter implants in hyperglycemic and normo-glycemic patients—a pilot study |
title_full_unstemmed | One-year performance of posterior narrow diameter implants in hyperglycemic and normo-glycemic patients—a pilot study |
title_short | One-year performance of posterior narrow diameter implants in hyperglycemic and normo-glycemic patients—a pilot study |
title_sort | one-year performance of posterior narrow diameter implants in hyperglycemic and normo-glycemic patients—a pilot study |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602141/ https://www.ncbi.nlm.nih.gov/pubmed/33939006 http://dx.doi.org/10.1007/s00784-021-03957-x |
work_keys_str_mv | AT friedmannanton oneyearperformanceofposteriornarrowdiameterimplantsinhyperglycemicandnormoglycemicpatientsapilotstudy AT winklermarianna oneyearperformanceofposteriornarrowdiameterimplantsinhyperglycemicandnormoglycemicpatientsapilotstudy AT diehldaniel oneyearperformanceofposteriornarrowdiameterimplantsinhyperglycemicandnormoglycemicpatientsapilotstudy AT yildizmehmetselim oneyearperformanceofposteriornarrowdiameterimplantsinhyperglycemicandnormoglycemicpatientsapilotstudy AT bilhanhakan oneyearperformanceofposteriornarrowdiameterimplantsinhyperglycemicandnormoglycemicpatientsapilotstudy |